UK becomes first in world to approve Covid vaccine as Pfizer gets green light

Filed under: All News,more news,Opinion,RECENT POSTS,Somali news |
A nurse in PPE and the coronavirus vaccine
The UK had previously secured 40 million doses of the jab (Picture: Reuters)
The UK has become the first country in the world to approve the Covid-19 Pfizer vaccine. The Department of Health said it will be rolled out from next week after being approved for use by the UK’s health regulation authority. A spokesman said: ‘The government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine for use. ‘The vaccine will be made available across the UK from next week.

The UK had previously secured orders for 40 million doses of the Pfizer/BioNTech jab – enough to vaccine 20 million people with two does each. The first people to be vaccinated will be high risk groups such as care home staff and residents, with a full priority list expected to be published later today. Health Secretary Matt Hancock declared ‘help is on its way’ as he confirmed the good news in a tweet. He said the health service is ready to start vaccinating from early next week, adding: ‘The UK is the first country in the world to have a clinically approved vaccine for supply


 Matt Hancock
 @MattHancock
Help is on its way. The MHRA has formally authorised the Pfizer/BioNTech vaccine for Covid-19. The NHS stands ready to start vaccinating early next week. The UK is the first country in the world to have a clinically approved vaccine for supply.

 However, the Government has previously ruled out ‘vaccine passports’. The European Medicines Agency has said it will convene a meeting on December 29 to decide if there is enough data about the safety and efficacy of the Pfizer/BioNTech for it to be approved. The agency also said Tuesday it could decide as early as January 12 whether to approve an experimental Covid-19 vaccine developed by Moderna.

Pfizer say the jab is 95% effective and has passed its safety checks. It has to be stored a very low temperatures, which Mr Hancock described as a ‘challenge’ but one the NHS was prepared for. He told Sky News ‘This is a challenging rollout and the NHS in all parts of the UK stands ready to make that happen. ‘They are used to handling vaccines and medicines like this, with these sorts of conditions. ‘It’s not easy but we’ve got those plans in place, so this morning I spoke to my counterparts in the devolved nations to make sure that we are all ready to roll out this vaccine … from early next week.’ Chairman and chief executive officer Dr Albert Bourla said previously: ‘We have known since the beginning of this journey that patients are waiting, and we stand ready to ship Covid-19 vaccine doses as soon as potential authorisations will allow us.’ The vaccine is one of a number of jabs that had been racing for official approval. 

epa08814068 An undated handout picture made available by the German pharmaceutical company Biontec shows the dosing of BNT162b2, the mRNA-based vaccine candidate against COVID-19, during the clinical test.
A volunteer is injected with the Pfizer/BioNtech jab during testing (Picture: EPA)

The UK government have agreed a deal to get 100 million doses of the Oxford and Astrazeneca jab, which is said to be up to 90% effective – though questions have been raised about that figure.  It also plans to bring in seven million doses of the Moderna vaccine, which – like the Pfizer jab but unlike Oxford’s version – needs to be stored at very low temperatures. Moderna says its product is ’95% effective’ Russia also claims its Sputnik vaccine has the same level of effectiveness, but the UK is likely to reject that jab, according to The Daily Telegraph.  Each vaccine will become available to the public at different times based on authorisation and when the UK receives its doses.

 

Source:metro.co.uk/

/